The “obesity paradox” in dosing: a comprehensive analytical review of cockcroft–gault versus CKD-EPI for predicting clearance of narrow-therapeutic-index drugs in patients with BMI > 40 kg/m²

Arbind Kumar Choudhary

Open source

DOI
10.1007/s00228-026-04163-y
Published
2026-08-12
Container
European Journal of Clinical Pharmacology
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00228-026-04163-y,
  title = {The “obesity paradox” in dosing: a comprehensive analytical review of cockcroft–gault versus CKD-EPI for predicting clearance of narrow-therapeutic-index drugs in patients with BMI \> 40 kg/m²},
  author = {Arbind Kumar Choudhary},
  year = {2026},
  journal = {European Journal of Clinical Pharmacology},
  doi = {10.1007/s00228-026-04163-y},
  url = {https://doi.org/10.1007/s00228-026-04163-y}
}

RIS

TY  - JOUR
TI  - The “obesity paradox” in dosing: a comprehensive analytical review of cockcroft–gault versus CKD-EPI for predicting clearance of narrow-therapeutic-index drugs in patients with BMI > 40 kg/m²
AU  - Arbind Kumar Choudhary
PY  - 2026
JO  - European Journal of Clinical Pharmacology
DO  - 10.1007/s00228-026-04163-y
UR  - https://doi.org/10.1007/s00228-026-04163-y
ER  - 

APA

Choudhary, A. K. (2026). The “obesity paradox” in dosing: a comprehensive analytical review of cockcroft–gault versus CKD-EPI for predicting clearance of narrow-therapeutic-index drugs in patients with BMI > 40 kg/m². European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-026-04163-y

Source records